Homepage > Arena > 23andMe

Invest in 23andMe shares

  • Category Biotechnology
  • Investment Type Private Stocks Seller
  • Year Founded 2006
  • Amount Raised For 'Accredited Investors'
  • Available Offers Up to 50 offers available


Location: United States

Employees: 501-1000

Category: Biotechnology, Consumer, Genetics

Company Overview:

23andMe is a human genome research company enabling users to study their ancestry, genealogy, and inherited traits.

A startup co-founded by Linda Avey and Anne Wojcicki, the wife of Google co-founder Sergey Brin, 23andMe has plans to make the human genome searchable. Brin, along with Google, gave 23andMe $3.9 million as part of a series A in May of 2007.

The company was named after the number of chromosome pairs in humans. They aim to help people understand what their genes mean by indexing them and highlighting significant findings.

23andMe allows its clients/users to study their ancestry, genealogy, and inherited traits. The company also markets to researchers and scientists, for whom they provide neatly categorized and easily searchable data.

One reason the Google investment in 23andMe made sense, was that this company could enable the search giant to index another facet of the world’s information. With the Biotech and Health Care industries growing rapidly, 23andMe could help Google get and maintain a market hold in these already multi-billion-dollar areas.


Need more insights?

The Due Diligence Report for 23andMe, prepared with crowd analysis and predictive algorithms, perfect for investment assessment, research and general in depth analysis.

View Report It's Free


Anne Wojcicki
Co-Founder & CEO
Linda Avey
Paul Cusenza

Leading Investors:

  • Google Ventures

  • New Enterprise Associates

  • Johnson & Johnson

  • Roche Venture Fund

  • MPM Capital

  • Sequoia Capital

  • Euclidean Capital

  • Altimeter Capital

  • GlaxoSmithKline

  • Fidelity Management

  • Casdin Capital

  • WuXi Venture Fund

Similar Companies:

Gene by Gene

Specializing in DNA-based ancestry & genealogy as Family Tree DNA.

Ambry Genetics

Ambry leads in clinical genetic diagnostics and genetics software solutions.

IDC Technologies

IDC Technologies provides information technology and consulting services.

Content & Privacy:

Confidentiality: The Elephant, the online trading arena, provides a balance between the private shareholders (employees and former employees) need to protect its confidential information and the investor’s need for the transparency necessary to make an informed investment decision.

Content Sources: All the information presented above was retrieved from public sources (media, company website, data from the registrar of private shareholder, etc.).

Responsibility: The Elephant does not accept any responsibility or liability for the accuracy, content and reliability of this information.

Diversify your investments portfolio with investments that provide access to private securities and pre-IPO leading high-tech private growth companies.

The information included in this website is intended to “Accredited Investors” only, as this term is defined in the jurisdiction in which they reside (or such similar term in such jurisdictions financial regulations).

Please note that the purchase of the shares of any Target Company may be subjected to right of first refusal of other shareholders, in some cases also to approval of the Target Company’s board of directors or other transfer restrictions as may be applicable.

Got A Question? Ask Us Now:

Full Name: *

Email: *


Your message: